See more : Gold Road Resources Limited (GOR.AX) Income Statement Analysis – Financial Results
Complete financial analysis of SCWorx Corp. (WORX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of SCWorx Corp., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Delta Corp Limited (DELTACORP.NS) Income Statement Analysis – Financial Results
- Central Japan Railway Company (CJPRY) Income Statement Analysis – Financial Results
- Fintech Ecosystem Development Corp. (FEXDR) Income Statement Analysis – Financial Results
- NATCO Pharma Limited (NATCOPHARM.NS) Income Statement Analysis – Financial Results
- Jaguar Global Growth Corporation I (JGGCU) Income Statement Analysis – Financial Results
SCWorx Corp. (WORX)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.scworx.com
About SCWorx Corp.
SCWorx Corp. develops and markets health care information technology solutions and related services to improve healthcare processes and information flow within hospitals and other healthcare facilities in the United States. The company provides data content and services related to repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. It also offers virtualized item master file repair, expansion and automation; EMR management; CDM management; contract management; request for proposal automation; rebate management; integration of acquired management; big data analytics modeling; data integration and warehousing; and ScanWorx. In addition, the company operates an online event ticketing platform focused on serving regional mixed martial arts. In addition, it offers CageTix, a ticketing platform for mixed martial arts industry. Further, the company focuses on selling personal protective equipment and COVID-19 rapid test kits. It sells its solutions and services to hospitals and health systems through its direct sales force, and distribution and reseller partnerships. SCWorx Corp. is based in New York, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.80M | 4.04M | 4.63M | 5.21M | 5.55M | 150.09K | 4.22M | 591.44K | 0.00 |
| Cost of Revenue | 2.54M | 2.62M | 2.78M | 3.52M | 4.38M | 2.91M | 2.69M | 384.42K | 0.00 |
| Gross Profit | 1.27M | 1.41M | 1.85M | 1.70M | 1.17M | -2.76M | 1.53M | 207.02K | 0.00 |
| Gross Profit Ratio | 33.35% | 35.01% | 39.94% | 32.57% | 21.02% | -1,841.73% | 36.19% | 35.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.12M | 0.00 |
| General & Administrative | 2.05M | 3.54M | 5.66M | 7.74M | 13.06M | 3.50M | 9.22M | 5.12M | 0.00 |
| Selling & Marketing | 672.35K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 2.72M | 3.54M | 5.66M | 7.74M | 13.06M | 3.50M | 9.22M | 5.12M | 386.46K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 143.66K | 231.04K | -16.86K | -3.35K | 0.00 |
| Operating Expenses | 2.72M | 3.54M | 5.66M | 7.74M | 13.06M | 3.50M | 9.22M | 5.12M | 386.46K |
| Cost & Expenses | 5.26M | 6.16M | 8.45M | 11.26M | 17.45M | 3.50M | 11.91M | 5.50M | 386.46K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 37.77K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 6.45K | 3.16K | 0.00 | 0.00 | 23.72K | 258.80K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | -2.52M | 76.16K | 76.16K | 234.26K | 41.23K | 40.83K | 76.18K | 397.44K | 0.00 |
| EBITDA | -3.97M | -1.85M | -3.74M | -5.81M | -11.25M | -3.58M | -3.09M | -4.52M | -386.46K |
| EBITDA Ratio | -104.46% | -59.58% | -80.70% | -111.46% | -210.43% | -2,206.31% | -77.91% | -763.27% | 0.00% |
| Operating Income | -1.45M | -2.13M | -3.81M | -6.05M | -11.90M | -3.58M | -11.27M | -4.91M | -386.46K |
| Operating Income Ratio | -38.13% | -52.66% | -82.34% | -115.96% | -214.44% | -2,387.45% | -267.29% | -830.47% | 0.00% |
| Total Other Income/Expenses | -2.53M | 279.19K | 0.00 | -1.36M | 584.99K | -204.20K | -2.87M | -3.35K | 4.00 |
| Income Before Tax | -3.98M | -1.85M | -3.81M | -7.40M | -11.31M | -3.79M | -11.29M | -4.92M | -386.46K |
| Income Before Tax Ratio | -104.63% | -45.75% | -82.34% | -141.99% | -203.90% | -2,523.50% | -267.69% | -831.03% | 0.00% |
| Income Tax Expense | 0.00 | -279.19K | 2.00 | 27.97K | 167.38K | 10.80M | 688.11K | -755.65K | 0.00 |
| Net Income | -3.98M | -1.57M | -3.81M | -7.40M | -11.48M | -14.59M | -11.98M | -4.16M | -386.46K |
| Net Income Ratio | -104.63% | -38.83% | -82.34% | -141.99% | -206.91% | -9,722.40% | -284.01% | -703.27% | 0.00% |
| EPS | -3.86 | -1.97 | -5.44 | -12.26 | -27.49 | -269.00 | -319.66 | -122.56 | -33.04 |
| EPS Diluted | -3.86 | -1.97 | -5.44 | -12.26 | -27.49 | -269.00 | -319.66 | -122.56 | -33.04 |
| Weighted Avg Shares Out | 1.03M | 797.87K | 700.56K | 603.81K | 417.59K | 54.25K | 37.47K | 19.37K | 35.09K |
| Weighted Avg Shares Out (Dil) | 1.03M | 797.87K | 700.56K | 603.81K | 417.59K | 54.25K | 37.47K | 19.37K | 35.09K |
Want to Make $1 Million? Market Manipulation Is Back!
WORX Stock: 6 Things to Know About New Short-Squeeze Play SCWorx
WORX Stock: Meme Investors Are Looking to Squeeze SCWorx Next
Best Biotech Penny Stocks to Buy in July 2021? 6 For Your Watchlist
WORX Stock Increases Over 70% Intraday: Why It Happened
SCWorx Announces Compliance with Nasdaq Listing Standards and Appointment of Tim Hannibal as CEO
Nasdaq issues SCWorx Notice of Deficiency Due to Company's 2020 Form 10K not yet being Filed
SCWorx has appointed Alton Irby to serve as a member of the Board of Directors effective immediately
MARC SCHESSEL TRANSITIONING TO SCWORX CONSULTANT ROLE
Source: https://incomestatements.info
Category: Stock Reports